Therapeutic Asset Ratings
3,774 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Autologous Tolerogenic Dendritic Cells
Relapsing-Remitting Multiple Sclerosis
Judit Pich
P2
CCC
(53)
Axicabtagene Ciloleucel
Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
City of Hope Medical Center
P2
CCC
(53)
Axicabtagene Ciloleucel
High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit
City of Hope Medical Center
P2
CCC
(53)
Axicabtagene Ciloleucel
Transformed Follic Lymph to Diff Large B-Cell Lymphoma
SWOG Cancer Research Network
P2
CCC
(53)
Bcma Car-T Cells
Neoplasm
Zhejiang University
P2
CCC
(53)
Bcma Car-T Cells
Relapsed/Refractory
The First Affiliated Hospital of Xiamen University
P2
CCC
(53)
Bcma-Cd19 Ccar T Cells
Acquired Thrombotic Thrombocytopenic Purpura
Peking University People's Hospital
P2
CCC
(53)
Bcma-Cd19 Ccar T Cells
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Peking University People's Hospital
P2
CCC
(53)
Bcma-Cd19 Ccar T Cells
Antiphospholipid Syndrome
Peking University People's Hospital
P2
CCC
(53)
Bcma-Cd19 Ccar T Cells
Behcet Disease
Peking University People's Hospital
P2
CCC
(53)
Bcma-Cd19 Ccar T Cells
Immunoglobulin G4-Related Sclerosing Disease
Peking University People's Hospital
P2
CCC
(53)
Bcma-Cd19 Ccar T Cells
Myositis Disease
Peking University People's Hospital
P2
CCC
(53)
Bcma-Cd19 Ccar T Cells
Sjogren Syndrome
Peking University People's Hospital
P2
CCC
(53)
Bcma-Cd19 Ccar T Cells
Systemic Lupus Erythematosus
Peking University People's Hospital
P2
CCC
(53)
Bcma-Cd19 Ccar T Cells
Systemic Sclerosis
Peking University People's Hospital
P2
CCC
(53)
Brexucabtagene Autoleucel
Burkitt Lymphoma
Kite, A Gilead Company
P2
CCC
(53)
Brexucabtagene Autoleucel
Hairy Cell Leukemia
Kite, A Gilead Company
P2
CCC
(53)
Brexucabtagene Autoleucel
Richter Transformation
Kite, A Gilead Company
P2
CCC
(53)
Brexucabtagene Autoleucel
Waldenstrom Macroglobulinemia
Kite, A Gilead Company
P2
CCC
(53)
CART-ddBCMA
Anitocabtagene Autoleucel
PETHEMA Foundation
P2
CCC
(53)
cd19car-cd28-cd3zeta-egfrt-expressing tn/mem-enriched t-lymphocytes
Mantle Cell Lymphoma
City of Hope Medical Center
P2
CCC
(53)
cd19-cart
Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P2
CCC
(53)
cd19/cd22-bispecific car-t cells
Large B-Cell Lymphoma (LBCL)
Beijing Tongren Hospital
P2
CCC
(53)
cd19+cd22 car-t
Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
cd19-ucart
Large B-Cell Lymphoma
Zhejiang University
P2
CCC
(53)
Showing 276 to 300 of 3,774 assets
Previous
Page 12 of 151
Next